Thromb Haemost 2006; 96(06): 859-861
DOI: 10.1160/TH06-03-0180
Letters to the Editor
Schattauer GmbH

Exercise increases tissue-type plasminogen activator expression in rat cardiomyocytes

Hubert P. Walinski
1   Laboratory of Dynamic Cellular Imaging and Biophysics, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada
,
Steve F. Gyorffy
1   Laboratory of Dynamic Cellular Imaging and Biophysics, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada
,
Hon S. Leong
1   Laboratory of Dynamic Cellular Imaging and Biophysics, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada
,
Graham R. D. Slaughter
2   Heart and Stroke/Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
,
Fayez Dawood
2   Heart and Stroke/Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
,
Gordon E. Pate
1   Laboratory of Dynamic Cellular Imaging and Biophysics, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada
,
Peter P. Liu
2   Heart and Stroke/Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
,
Thomas G. Parker
3   Division of Cardiology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
,
Thomas J. Podor
1   Laboratory of Dynamic Cellular Imaging and Biophysics, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital/University of British Columbia, Vancouver, British Columbia, Canada
› Author Affiliations
Further Information

Publication History

Received 28 March 2006

Accepted 18 October 2006

Publication Date:
29 November 2017 (online)

 

 
  • References

  • 1 Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-801.
  • 2 Verheugt FW, ten Cate JW, Sturk A. et al. Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 1987; 59: 1075-9.
  • 3 Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000; 46: 250-6.
  • 4 Creemers E, Cleutjens J, Smits J. et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000; 156: 1865-73.
  • 5 Li WY, Chong SS, Huang EY. et al. Plasminogen activator/plasmin system: a major player in wound healing?. Wound Repair Regen 2003; 11: 239-47.
  • 6 Bansal DD, Klein RM, Hausmann EH. et al. Secretion of cardiac plasminogen activator during hypoxiainduced right ventricular hypertrophy. J Mol Cell Cardiol 1997; 29: 3105-14.
  • 7 Bloor CM, Nimmo L, McKirnan MD. et al. Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Mol Cell Biochem 1997; 176: 265-71.
  • 8 Orenstein TL, Parker TG, Butany JW. et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 1995; 96: 858-66.
  • 9 Lindahl B, Nilsson TK, Jansson JH. et al. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 1999; 246: 105-12.
  • 10 van den Burg PJ, Hospers JE, van Vliet M. et al. Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men. J Appl Physiol 1997; 82: 613-20.
  • 11 Chandler WL, Levy WC, Stratton JR. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation 1995; 92: 2984-94.
  • 12 van den Burg PJ, Dooijewaard G, van Vliet M. et al. Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters. Thromb Haemost 1994; 71: 236-9.
  • 13 Raghunath PN, Tomaszewski JE, Brady ST. et al. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1432-43.
  • 14 Tyagi SC, Lewis K, Pikes D. et al. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol 1998; 176: 374-82.
  • 15 Bankl HC, Radaszkiewicz T, Pikula B. et al. Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis. Hum Pathol 1997; 28: 1283-90.
  • 16 Ennis IL, Escudero EM, Console GM, Camihort G, Dumm CG, Seidler RW. et al. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension 2003; 41: 1324-9.
  • 17 Heymans S, Luttun A, Nuyens D. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 05: 1135-42.